Hikma Pharmaceutical | HIK - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Almirall EUR 2.39B 61.32M 2026-07
argenx SE USD 48.46B 9.17B 2026-07
AstraZeneca USD 301.25B 13.1B 2026-03
Bayer EUR 38.69B 2.33B 2026-03
Genmab DKK 20.48B 1.02B 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Lakefront Biotherapeutics EUR 1.73B 119.93M 2026-03
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 46.78B 6.52B 2026-03
Orion EUR 7.95B 2.2B 2026-07
Recordati EUR 10.26B 104.56M 2026-03
Roche Holding CHF 235.82B 34.18B 2026-07
Sanofi EUR 100.27B 605.48M 2026-03
UCB EUR 46.41B 13.94B 2025-12